Skip to main content Accessibility help
×
Home
  • Print publication year: 2010
  • Online publication date: November 2010

11 - Body dysmorphic disorder

Summary

This chapter provides an overview of psychological accounts of specific phobia and describes a standard protocol for in vivo exposure, the current treatment of choice for specific phobia. Specific phobia is one of the most common psychiatric disorders in the general population, with documented lifetime prevalence estimates ranging between 9.4% and 12.5%. Specific phobias frequently co-occur with other DSM-IV disorders as an additional diagnosis, particularly when the predominant diagnosis is an anxiety disorder or a mood disorder. Behavioral treatments for specific phobias are rooted in Mowrer's classic two-stage theory of fear development. The chapter examines the role of cognitive factors in specific phobia. Recent research suggests that visual and somatic mental imagery may also play a role in the maintenance of specific phobia. There are a number of challenges that clinicians and clients may encounter during exposure treatment for specific phobia.

References

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn., text revision. Washington, DC: APA, 2000.
2. PhillipsKA.Psychosis in body dysmorphic disorder. J Psychiatr Res 2004; 38: 63–72.
3. PhillipsKA, MenardW, FayC, WeisbergR.Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with body dysmorphic disorder. Psychosomatics 2005; 46: 317–25.
4. PhillipsKA, McElroySL, KeckPE, et al. A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. Psychopharmacol Bull 1994; 30: 179–86.
5. PhillipsKA.The Broken Mirror: Understanding and Treating Body Dysmorphic Disorder (revised and expanded edition). Oxford: Oxford University Press, 2005.
6. PhillipsKA, McElroySL, KeckPE Jr, PopeHG, HudsonJI. Body dysmorphic disorder: 30 cases of imagined ugliness. Am J Psychiatry 1993; 150: 302–8.
7. PhillipsKA, MenardW, FayC.Gender similarities and differences in 200 individuals with body dysmorphic disorder. Compr Psychiatr 2006; 47: 77–87.
8. PopeCG, PopeHG, MenardW, et al. Clinical features of muscle dysmorphia among males with body dysmorphic disorder. Body Image 2005; 2: 395–400.
9. GrantJE, MenardW, PhillipsKA.Pathological skin picking in individuals with body dysmorphic disorder. Gen Psychiatry 2006; 28: 487–93.
10. PhillipsKA, TaubSL. Skin picking as a symptom of body dysmorphic disorder. Psychopharmacol Bull 1995; 31: 279–88.
11. VealeD, BoocockA, GournayK, et al. Body dysmorphic disorder: a survey of fifty cases. Br J Psychiatry 1996; 169: 196–201.
12. CrerandCE, PhillipsKA, MenardW, FayC. Non-psychiatric medical treatment of body dysmorphic disorder. Psychosomatics 2005; 46: 549–55.
13. PhillipsKA, GrantJ, SiniscalchiJ, Albertini RS. Surgical and nonpsychiatric medical treatment of patients with body dysmorphic disorder.Psychosomatics 2001; 42: 504–10.
14. SarwerDB, CrerandCE.Body dysmorphic disorder and appearance enhancing medical treatments. Body Image 2008; 5: 50–8.
15. PhillipsKA, MenardW.Suicidality in body dysmorphic disorder: a prospective study. Am J Psychiatry 2006; 163: 1280–2.
16. RiefW, BuhlmannU, WilhelmS, et al. The prevalence of body dysmorphic disorder: a population-based survey. Psychol Med 2006; 36: 877–85.
17. BienvenuOJ, SamuelsJF, RiddleMA, et al. The relationship of obsessive–compulsive disorder to possible spectrum disorders: results from a family study. Biol Psychiatry 2000; 48: 287–93.
18. OttoMW, WilhelmS, CohenLS, HarlowBL. Prevalence of body dysmorphic disorder in a community sample of women. Am J Psychiatry 2001; 158: 2061–3.
19. GrantJE, KimSW, CrowSJ. Prevalence and clinical features of body dysmorphic disorder in adolescent and adult psychiatric inpatients. J Clin Psychiatry 2001; 62: 517–22.
20. ConroyM, MenardW, Fleming-IvesK, ModhaP, PhillipsKA. Prevalence and clinical characteristics of body dysmorphic disorder in an adult inpatient setting. Gen Hosp Psychiatry 2008; 30: 67–72.
21. PhillipsKA, DidieER, MenardW. Clinical features and correlates of major depressive disorder in individuals with body dysmorphic disorder. J Affect Disord 2007; 97: 129–35.
22. NierenbergAA, PhillipsKA, PetersonTJ, Kelly, et al. Body dysmorphic disorder in outpatients with major depression. J Affect Disord 2002; 69: 141–8.
23. WilhelmS, OttoMW, ZuckerBG, PollackMH. Prevalence of body dysmorphic disorder in patients with anxiety disorders. J Anxiety Disord 1997; 11: 499–502.
24. PhillipsKA, DufresneRG, WilkelC, VittorioC. Rate of body dysmorphic disorder in dermatology patients. J Am Acad Dermatol 2000; 42: 436–41.
25. SarwerDB, WaddenTA, PertschukMJ, WhitakerLA. The psychology of cosmetic surgery: a review and reconceptualization. Clin Psychol Rev 1998; 18: 1–22.
26. CrerandCE, SarwerDB, MageeL, et al. Rate of body dysmorphic disorder among patients seeking facial cosmetic procedures. Psychiat Ann 2004; 34: 958–65.
27. PhillipsKA, DiazSF. Gender differences in body dysmorphic disorder. J Nerv Ment Dis 1997; 185: 570–7.
28. GunstadJ, PhillipsKA.Axis I comorbidity in body dysmorphic disorder. Compr Psychiatr 2003; 44: 270–6.
29. NezirogluF, McKayD, TodaroJ, Yaryura-TobiasJA. Effects of cognitive behavior therapy on persons with body dysmorphic disorder and comorbid axis II diagnoses. Behav Ther 1996; 27: 67–77.
30. PhillipsKA.Suicidality in body dysmorphic disorder. Prim Psychiatry 2007; 14: 58–66.
31. PhillipsKA, ColesME, MenardW, et al. Suicidal ideation and suicide attempts in body dysmorphic disorder. J Clin Psychiatry 2005; 66: 717–25.
32. PhillipsKA. Quality of life for patients with body dysmorphic disorder. J Nerv Ment Dis 2000; 188: 170–5.
33. WilhelmS.Feeling Good about the Way You Look: A Program for Overcoming Body Image Problems. New York: Guilford Press, 2006.
34. GroeszLM, LevineMP, MurnenSK. The effect of experimental presentation of thin media images on body satisfaction: a meta-analytic review. Int J Eat Disord 2002; 31: 1–16.
35. BuhlmannU, CookLM, FamaJM, WilhelmS.Perceived teasing experiences in body dysmorphic disorder. Body Image 2007; 4: 381–5.
36. WarrenCS, GleavesDH, Cepeda-BenitoA, del Carmen FernandezM, Rodriguez-RuizS. Ethnicity as a protective factor against internalization of a thin ideal and body dissatisfaction. Int J Eat Disord 2005; 37: 241–9.
37. BohneA, KeuthenNJ, WilhelmS, DeckersbachT, JenikeMA. Prevalence of symptoms of body dysmorphic disorder and its correlates: a cross-cultural comparison. Psychosomatics 2002; 43: 486–90.
38. HitzerothV, WesselsC, Zungu-DirwayiN, OosthuizenP, SteinDJ. Muscle dysmorphia: a South African sample. Psychiatry Clin Neurosci 2001; 55: 521–3.
39. SuzukiK, TakeiN, KawaiM, MinabeY, MoriN. Is taijin kyofusho a culture-bound syndrome?Am J Psychiatry 2003; 160: 1358.
40. UngEK, FonesCS, AngAW.Muscle dysmorphia in a young Chinese male. Ann Acad Med Singapore 2000; 29: 135–7.
41. CanseverA, UzunO, DonmezE, OzsahinA. The prevalence and clinical features of body dysmorphic disorder in college students: a study in a Turkish sample. Compr Psychiatry 2003; 44: 60–4.
42. FaravelliC, SalvatoriS, GalassiF, et al. Epidemiology of somatoform disorders: a community survey in Florence. Soc Psychiatry Psychiatr Epidemiol 1997; 32: 24–9.
43. TignolJ, Biraben-GotzamanisL, Martin-GuehlC, GrabotD, AouizerateB. Body dysmorphic disorder and cosmetic surgery: evolution of 24 subjects with a minimal defect in appearance 5 years after their request for cosmetic surgery. Eur Psychiatry 2007; 22: 520–4.
44. FontenelleLF, TellesLL, NazarBP, et al. A sociodemographic, phenomenological, and long-term follow-up study of patients with body dysmorphic disorder in Brazil. Int J Psychiatry Med 2006; 36: 243–59.
45. AltabeMN. Issues in the assessment and treatment of body image disturbance in culturally diverse populations. In ThompsonJK, ed., Body Image, Eating Disorders, and Obesity: An Integrative Guide for Assessment and Treatment. Washington, DC: American Psychological Association. 2001, pp. 129–47.
46. KawamuraKY.Asian American body images. In CashTF, PruzinskyT, eds., Body Image: A Handbook of Theory, Research and Clinical Practice. New York: Guilford Press. 2002, pp. 243–9.
47. ChowdhuryAN. The definition and classification of koro. Cult Med Psychiatry 1996; 20: 41–65.
48. PhillipsKA.Body dysmorphic disorder: recognizing and treating imagined ugliness. World Psychiatry 2004; 3: 12–17.
49. AltabeM, O’GaroKN. Hispanic body images. In CashTF, PruzinskyT, eds., Body Image: A Handbook of Theory, Research and Clinical Practice. New York: Guilford Press. 2002, pp. 250–6.
50. BuhlmannU, EtcoffNL, WilhelmS.Facial attractiveness ratings and perfectionism in body dysmorphic disorder and obsessive–compulsive disorder. J Anxiety Disord 2008; 22: 540–7.
51. DeckersbachT, SavageCR, PhillipsKA, et al. Characteristics of memory dysfunction in body dysmorphic disorder. J Int Neuropsych Soc 2000; 6: 673–81.
52. FeusnerJD, TownsendJ, BystritskyA, BookheimerS. Visual information processing of faces in body dysmorphic disorder. Arch Gen Psychiatry 2007; 64: 1417–25.
53. SaxenaS, FeusnerJD. Toward a neurobiology of body dysmorphic disorder. Prim Psychiatry 2006; 13: 41–8.
54. HollanderE, AllenA, KwonJ, et al. Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Arch Gen Psychiatry 1999; 56: 1033–9.
55. PerugiG, GiannottiD, Di VaioS, et al. Fluvoxamine in the treatment of body dysmorphic disorder (dysmorphophobia). Int Clin Psychopharmacol 1996; 11: 247–54.
56. PhillipsKA, DwightMM, McElroySL. Efficacy and safety of fluvoxamine in body dysmorphic disorder. J Clin Psychiatry 1998; 59: 165–71.
57. PhillipsKA, AlbertiniRS, RasmussenSA. A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Arch Gen Psychiatry 2002; 59: 381–8.
58. PhillipsKA, NajjarF. An open-label study of citalopram in body dysmorphic disorder. J Clin Psychiatry 2003; 64: 715–20.
59. PhillipsKA. An open-label study of escitalopram in body dysmorphic disorder. Int Clin Psychopharmacol 2006; 21: 177–9.
60. PhillipsKA, HollanderE.Treating body dysmorphic disorder with medication: evidence, misconceptions, and a suggested approach. Body Image. Int Journal Res 2008; 5: 13–27.
61. McKayD, TodaroJ, NezirogluF, et al. Body dysmorphic disorder: a preliminary evaluation of treatment and maintenance using exposure with response prevention. Behav Res Ther 1997; 35: 67–70.
62. VealeD, GournayK, DrydenW, et al. Body dysmorphic disorder: a cognitive behavioural model and pilot randomized controlled trial. Behav Res Ther 1996; 34: 717–29.
63. WilhelmS, OttoMW, LohrB, DeckersbachT. Cognitive behavior group therapy for body dysmorphic disorder: a case series. Behav Res Ther 1999; 37: 71–5.
64. RosenJC, ReiterJ, OrosanP. Cognitive–behavioral body image therapy for body dysmorphic disorder. J Consult Clin Psych 1995; 63: 263–9.
65. WilliamsJ, HadjistavropoulosT, SharpeD. A meta-analysis of psychological and pharmacological treatments for body dysmorphic disorder. Behav Res Ther 2006; 44: 99–111.
66. FirstMB, SpitzerRL, GibbonM, WilliamsJB.Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P). New York: Biometrics Research, New York State Psychiatric Institute, 2002.
67. PhillipsKA, HollanderE, RasmussenSA, et al. A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale–Brown Obsessive Compulsive Scale. Psychopharmacol Bull 1997; 33: 17–22.
68. BeckAT, SteerRA, BrownGK.Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation, 1996.
69. WilhelmS, PhillipsKA, SteketeeG.A Cognitive Behavioral Treatment Manual for Body Dysmorphic Disorder. New York: Guilford Press, in press.
70. RosenJC.Cognitive–behavioral body image therapy. In GarnerDM, GarfinkelPE, eds. Handbook of Treatment for Eating Disorders, 2nd edn. New York: Guilford Press. 2007, p. 188.
71. MarquesL, GreenbergJL, WilhelmS.Adapting CBT for Ethnic Minorities, Children and Adolescents with BDD. Proceedings of the 15th Annual OCF Conference; 2008 Aug 1–3; Boston, MA.